Background Sustained acid inhibition with PPI stimulates gastrin secretion, exerting a proliferative drive on enterochromaffin-like cells (ECL cells) of the oxyntic mucosa. It may also accelerate development of gastric gland atrophy in Helicobacter pylori-infected individuals. Aims To evaluate gastric exocrine and endocrine cell changes in GERD...
-
2012 (v1)PublicationUploaded on: April 14, 2023
-
2015 (v1)Publication
Control of chronic gastro-oesophageal reflux disease may be achieved either by anti-reflux surgery (ARS) or by long-term medical therapy with proton pump inhibitors (PPIs). The primary efficacy results of the SOPRAN study, comparing long-term omeprazole use with open ARS, and the LOTUS study, comparing long-term esomeprazole use with...
Uploaded on: March 27, 2023 -
2017 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2017 (v1)Publication
Background: Proton pump inhibitors and laparoscopic anti-reflux surgery (LARS) offer long-term symptom control to patients with gastro-oesophageal reflux disease (GERD). Aim: To evaluate the process of 'normalisation' of the squamous epithelium morphology of the distal oesophagus on these therapies. Methods: In the LOTUS trial, 554 patients...
Uploaded on: March 27, 2023